Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “antagonist”

678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 678
Index total 30,257
Page 20 / 29

Quick answer

This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

678 results for “antagonist” · 30,257 patents in full index Clear search

  1. US 8088926

    Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Jenrin Discovery, LLC · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted
  2. US 8088809

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted
  3. US 8084614

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted
  4. US 8071807

    Antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  5. US 8071074

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  6. US 8067445

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  7. US 8067439

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  8. US 8058300

    Polycyclic antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted
  9. US 8053448

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted
  10. US 8048418

    Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  11. US 8048844

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  12. US 8049015

    Heteroaryl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  13. US 8048902

    Antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  14. US 8039489

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted
  15. US 8034826

    Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  16. US 8034946

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  17. US 8017783

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted
  18. US 8017617

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted
  19. US 8013152

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted
  20. US 7960385

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  21. US 7947710

    Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted May 24, 2011 · Expires May 19, 2031

    granted
  22. US 7943131

    Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists

    GENERAL REGENERATIVES, LTD. · Granted May 17, 2011 · Expires May 12, 2031

    granted
  23. US 7943159

    Female sex pheromone of the dogwood borer (DWB), Synanthedon scitula, and attraction inhibitor (antagonist)

    The United States of America, as represented by the Secretary of Agriculture · Granted May 17, 2011 · Expires May 12, 2031

    granted
  24. US 7927583

    Receptor based antagonists and methods of making and using

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted